Chapter 32 (3) Flashcards
Prior to developing a plan for the treatment of asthma, the patient’s asthma should be classified
according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is classified as asthma symptoms that occur:
More than twice a week and less than once a day
In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms occur:
At nighttime three to four times a month
One goal of asthma therapy outlined by the NHLBI Expert Panel 3 guidelines is:
Require infrequent use of beta 2 agonists (albuterol) for relief of symptoms
A stepwise approach to the pharmacologic management of asthma:
Begins with determining the severity of asthma and assessing asthma control
Treatment for mild intermittent asthma is:
Short-acting beta-2-agonists (albuterol) as needed
The first-line therapy for mild-persistent asthma is:
Low-dose inhaled corticosteroids
Monitoring a patient with persistent asthma includes:
Evaluating the patient every 1 to 6 months to determine if the patient needs to step up or down in their therapy
Asthma exacerbations at home are managed by the patient by:
Increasing frequency of beta-2-agonists and contacting their provider
Patients who are at risk of a fatal asthma attack include patients:
With a history of requiring intubation or ICU admission for asthma
Pregnant patients with asthma may safely use _____ throughout their pregnancy.
Inhaled corticosteroids (budesonide)
One goal of asthma management in children is:
Participation in school and sports activities
Medications used in the management of patients with chronic obstructive pulmonary disease (COPD) include:
All of the above
Patients with a COPD exacerbation may require:
Systemic corticosteroid burst
Patients with COPD require monitoring of:
Beta-2-agonist use
Education of patients with COPD who use inhaled corticosteroids includes:
Rinsing their mouth after use
